CLINICAL_TRIALS
research
· 2025-11-04
Clinical Trial Update: Indocyanine Green (ICG) Guided Tumor Resection [Phase 1]
Summary
This clinical trial entry describes a Phase 1 study evaluating Indocyanine Green (ICG) guided tumor resection in patients with neoplastic diseases and solid tum…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Jude Children's Research Hospital | Conditions: Neoplastic Disease, Solid Tumor | Phase 1 | Status: RECRUITING